美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ASTRAZENECA PLC ADRhedged

53.28

0.0000

成交量：- -

成交額：- -

市值：159.83萬

市盈率：- -

高：53.28

開：53.28

低：53.28

收：53.28

52周最高：56.90

52周最低：44.36

股本：3.00萬

流通股本：1.00萬

量比：- -

換手率：- -

股息：0.58

股息率：1.08%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

聯合開發心臟藥物III期試驗未達主要終點，阿斯利康與Ionis股價暴跌

阿斯利康依普隆特生鈉注射液在華上市

聯合開發心臟藥物III期試驗未達主要終點阿斯利康(AZN.US)與Ionis(IONS.US)股價暴跌

道指期貨微跌不足0.1% 記憶體股盤前上升歐股早段普遍上升英藥廠阿斯利康挫10%

今日關注個股：李維斯、百事可樂、阿斯利康

阿斯利康心臟病藥物臨床試驗未達終點，股價暴跌9%

环球市场播报

阿斯利康盤前跌8.41%，現報173.37美元

每日经济新闻

美股異動丨阿斯利康盤前跌8.4%，Wainua後期試驗未達主要終點

美股夜盤 | 芯片、存儲、光通信概念股拉升，康寧升逾5%、英特爾、美光科技升逾3%；阿斯利康跌超7%，新藥臨床試驗未達預期

老虎资讯综合

歐股阿斯利康下跌9%此前其治療神經系統疾病的藥物WAINUA晚期臨床試驗未達預期。

阿斯利康股價下跌8.9%，原因是WAINUA未能達到主要終點。

阿斯利康發言人表示，正與英國國家醫療服務體系及英國國家健康與臨床優化研究所持續商討，以確定解決方案，支持患者獲得優赫得。

中國生物製藥分別與阿斯利康、葛蘭素史克達成重要合作

慢阻肺藥物市場掀起交易熱潮，阿斯利康19億美元拿下這款中國創新藥

港股異動 | 中國生物製藥(01177)早盤升逾4% 附屬與阿斯利康就TQC3721訂立獨家授權協議

最高19億美元，中國生物製藥與阿斯利康達成TQC3721獨家授權合作

中國生物製藥：與阿斯利康就TQC3721簽訂獨家許可協議，阿斯利康獲得TQC3721在中國境外的獨家授權，該協議可獲得2

數據簡報-隨着小型企業不斷湧現，減肥藥的上市競爭日益白熱化

阿斯利康(AZN)股票7月6日盤中下跌3.79%：投資者必看的核心信息

TradingKey中文

石藥集團盤初漲近7% 石藥集團與阿斯利康達成17.7億美元新合作

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/AZNH/news?page=6"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AZNH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","market":"US","secType":"STK","nameCN":"ASTRAZENECA PLC ADRhedged","latestPrice":53.2774,"timestamp":1789502400000,"preClose":53.2774,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":10000,"shares":30000,"eps":0,"marketStatus":"停牌","change":0,"latestTime":"09-15 16:00:00 EDT","open":53.2774,"high":53.2774,"low":53.2774,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"exchange":"NYSE","adjPreClose":53.2774,"dividendRate":0.010836,"bidAskSpread":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","floatShares":10000,"roa":"--","roe":"--","lyrEps":0,"shares":30000,"dividePrice":0.57729,"high":53.2774,"amplitude":0,"preClose":53.2774,"low":53.2774,"week52Low":44.36,"pbRate":"--","week52High":56.8955,"institutionHeld":0,"latestPrice":53.2774,"eps":0,"divideRate":0.010836,"volume":0,"delay":0,"ttmEps":0,"open":53.2774,"prevYearClose":54.226,"prevWeekClose":53.2774,"prevMonthClose":53.2774,"prevQuarterClose":53.2774,"fiveDayClose":53.2774,"twentyDayClose":53.2774,"sixtyDayClose":53.2774},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AZNH\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"AZNH","amount":0.57729,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2024-12-16","symbol":"AZNH","amount":2.71402,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-16","defaultRemindTime":1734359400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-23","payableDate":"2024-12-16","currency":"USD","dateTimestamp":1734325200000,"payDate":"2024-12-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AZNH\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-16","recordDate":"2024-12-16","paymentDate":"2024-12-23","value":2.71402,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.57729,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AZNH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AZNH\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2650929828","title":"聯合開發心臟藥物III期試驗未達主要終點，阿斯利康與Ionis股價暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2650929828","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650929828?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 19:57","pubTimestamp":1783598269,"startTime":"0","endTime":"0","summary":"7月9日，阿斯利康与IONS联合开发的一款实验性心脏病药物在后期临床试验中未能达到主要疗效终点，Ionis股价盘前下跌超20%，阿斯利康盘前跌超8%。","market":"us","thumbnail":"https://community-static.tradeup.com/news/56ac818c9a46212bd08488d4935a4dad","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/56ac818c9a46212bd08488d4935a4dad"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1465485.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2237443549.SGD","LU0708994859.HKD","BK4568","LU1267930573.SGD","BK4007","LU2237443622.USD","LU2417539215.USD","BK4585","AZNH","LU1829250122.USD","LU0889565916.HKD","BK4134","LU0058720904.USD","LU2468319806.SGD","AZN","LU2236285917.USD","LU2462157665.USD","LU0029864427.USD","BK4139","LU2237443895.HKD","LU2237443382.USD","LU0128525929.USD","BK4588","LU0432979614.USD","LU2237443465.HKD","IONS","III","IE00B3T34201.USD","LU0289739699.SGD","LU0310800379.SGD","LU0320765992.SGD","LU2089984988.USD","LU2237443978.SGD","LU2456880835.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2650092999","title":"阿斯利康依普隆特生鈉注射液在華上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2650092999","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650092999?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 19:42","pubTimestamp":1783597333,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","LU2089984988.USD","LU1267930573.SGD","LU0128525929.USD","BK4568","LU0708994859.HKD","LU2237443382.USD","LU2236285917.USD","LU1829250122.USD","IE00B3T34201.USD","LU0289739699.SGD","LU2237443465.HKD","LU0310800379.SGD","LU0889565916.HKD","LU0029864427.USD","LU2462157665.USD","LU2417539215.USD","BK4007","LU0058720904.USD","LU0320765992.SGD","AZNH","LU2237443622.USD","LU0109394709.USD","AZN","LU2468319806.SGD","LU2237443895.HKD","LU2237443978.SGD","BK4588","LU2237443549.SGD","LU2456880835.USD","IPOS","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650929827","title":"聯合開發心臟藥物III期試驗未達主要終點 阿斯利康(AZN.US)與Ionis(IONS.US)股價暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2650929827","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650929827?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 19:29","pubTimestamp":1783596558,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IONS","LU2237443382.USD","LU0289739699.SGD","AZN","LU2236285917.USD","BK4588","LU2456880835.USD","LU2417539215.USD","AZNH","LU0029864427.USD","BK4139","LU0058720904.USD","LU2237443622.USD","LU0310800379.SGD","LU1829250122.USD","LU2237443978.SGD","LU2468319806.SGD","BK4007","LU0708994859.HKD","LU0128525929.USD","LU0432979614.USD","LU0320765992.SGD","LU2237443895.HKD","BK4134","BK4585","IE00B3T34201.USD","LU0889565916.HKD","LU2462157665.USD","LU2237443549.SGD","LU2089984988.USD","BK4568","LU2237443465.HKD","LU1267930573.SGD","LU0109394709.USD","III"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650892399","title":"道指期貨微跌不足0.1%  記憶體股盤前上升  歐股早段普遍上升  英藥廠阿斯利康挫10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650892399","media":"AASTOCKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650892399?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 18:11","pubTimestamp":1783591860,"startTime":"0","endTime":"0","summary":"亚洲主要股市今日(9日)普遍上升。南韩KOSPI盘中曾升逾4%后一度倒跌，全日收升45点或0.6%，报7,291点。日经指数结束对上两日急跌势头，全日回升924点或1.4%报67,743点。中国内地A股三大指数收升1.65%至4.49%。港股收跌169点或0.7%，报24,030点。台股跌379点或0.8%，报45,3...","market":"us","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112144305039_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112144305039_s.jpg"],"rights":{"source":"aastocks_forex","url":"https://www.aastocks.com/sc/forex/news/comment.aspx?source=AAFN&id=NOW.1532601&catg=1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.aastocks.com/sc/forex/news/comment.aspx?source=AAFN&id=NOW.1532601&catg=1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_forex","symbols":["LU2237443549.SGD","IE00B3T34201.USD","LU2468319806.SGD","TOPT",".DJI","DIA","VXUS","LU2462157665.USD","LU0310800379.SGD","DGRW","SCHD","DOG","DGRO","LU2236285917.USD","LU0889565916.HKD","VYM","YMAX","DVY","DDM","DJX","UDOW","MGK","LU2237443382.USD","LU1267930573.SGD","DJIA","BK4588","YMmain","SDOW","BK4585","MYMmain","LU0128525929.USD","VGK","GRNY","AZNH","SCHG","DXD","FDN","FDVV","LU0289739699.SGD","SDY","AZN","FGBXmain","LU0029864427.USD","LU2237443622.USD","IEV","VYMI","LU0708994859.HKD","LU1829250122.USD","VUG","XLI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150820563","title":"今日關注個股：李維斯、百事可樂、阿斯利康","url":"https://stock-news.laohu8.com/highlight/detail?id=1150820563","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150820563?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 17:24","pubTimestamp":1783589097,"startTime":"0","endTime":"0","summary":"SK海力士：这家韩国芯片制造商预计将于今日为其明日在美国的上市定价，此举可能成为全球规模最大的股票发行之一。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","BK4550","LU2456880835.USD","LU2237443465.HKD","AZN","LU1244550494.USD","LU1244550577.SGD","LU0029864427.USD","LU2237443622.USD","LU2237443978.SGD","IE00BBT3K403.USD","LU2237443382.USD","LU1162221912.USD","LU0058720904.USD","LEVI","LU0889565916.HKD","LU2468319806.SGD","LU0320765646.SGD","FTXG","IE0000B7K699.USD","IE000BZT7R73.USD","LU1829250122.USD","LU0757428866.USD","BK4534","BK4568","IE00BN8TJ469.HKD","LU1815336091.USD","BK4007","BK4585","IE00BLSP4452.SGD","IE00BLSP4239.USD","BK4177","LU0234572021.USD","LU2237443549.SGD","LU2237443895.HKD","LU2236285917.USD","LU2462157665.USD","LU1244550221.USD","IE000SO60NU8.SGD","BK4588","ATZAF","IE000WAW04H5.SGD","BK4504","LU0098860793.USD","IE000F7OJYX1.SGD","LU2089984988.USD","BK4202","LU0708994859.HKD","LU0432979614.USD","BK4094","LU0109394709.USD","BK4533","BK4581","BK4566","LU0320765992.SGD","IE000MB6IJN5.SGD","LU1267930573.SGD","PEP","LU2417539215.USD","LU0289739699.SGD","LU1894683264.USD","LU0128525929.USD","AZNH","LU1929549753.HKD","IE00B3T34201.USD","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650360947","title":"阿斯利康心臟病藥物臨床試驗未達終點，股價暴跌9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650360947","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650360947?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 16:34","pubTimestamp":1783586040,"startTime":"0","endTime":"0","summary":"阿斯利康新药 Wainua 未能达成试验目标：无法降低罕见心脏病患者的死亡风险与复发性心脏急症发作概率。　　阿斯利康一款心脏病新药三期临床试验未达到预设疗效终点，公司股价盘中最大跌幅达 9%。　　伦敦市场最新行情显示，阿斯利康股价下跌 8.9%，或将创下 2020 年 3 月新冠疫情爆发以来最差单日表现。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-09/doc-inihewtc8659764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1267930573.SGD","IE00B3T34201.USD","LU2417539215.USD","BMED","BK4588","LU0320765992.SGD","LU2237443549.SGD","LU2237443465.HKD","BK4007","LU2462157665.USD","AZN","LU2237443978.SGD","LU2237443622.USD","LU0708994859.HKD","IBBQ","LU2237443895.HKD","LU0310800379.SGD","BK4568","LU0058720904.USD","LU0889565916.HKD","LU1829250122.USD","AZNH","LU0029864427.USD","LU0109394709.USD","LU0289739699.SGD","LU2236285917.USD","LU0432979614.USD","LU0128525929.USD","BK4585","LU2237443382.USD","LU2456880835.USD","LU2089984988.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650294728","title":"阿斯利康盤前跌8.41%，現報173.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650294728","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650294728?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 16:26","pubTimestamp":1783585586,"startTime":"0","endTime":"0","summary":"阿斯利康盘前跌8.41%，现报173.37美元","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607093800053797.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607093800053797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","UUP","UDN","LU2237443622.USD","LU2417539215.USD","LU0310800379.SGD","BK4568","LU2462157665.USD","LU0708994859.HKD","LU0058720904.USD","LU1829250122.USD","LU2237443895.HKD","LU2237443465.HKD","LU0029864427.USD","LU2236285917.USD","LU2237443978.SGD","LU0128525929.USD","LU0432979614.USD","LU2089984988.USD","LU1267930573.SGD","BK4585","LU2456880835.USD","AZN","LU2237443549.SGD","BK4007","LU0320765992.SGD","LU2237443382.USD","LU0889565916.HKD","LU0109394709.USD","LU0289739699.SGD","IE00B3T34201.USD","LU2468319806.SGD","AZNH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650665942","title":"美股異動丨阿斯利康盤前跌8.4%，Wainua後期試驗未達主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2650665942","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650665942?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 16:14","pubTimestamp":1783584873,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0432979614.USD","AZN","LU0109394709.USD","LU2237443465.HKD","BK4588","LU0058720904.USD","LU2417539215.USD","BK4568","LU0320765992.SGD","LU2236285917.USD","LU2237443895.HKD","LU2468319806.SGD","LU2237443622.USD","LU1829250122.USD","LU0310800379.SGD","IE00B3T34201.USD","BK4585","LU2237443382.USD","LU0128525929.USD","LU2237443549.SGD","LU0289739699.SGD","LU2237443978.SGD","LU2456880835.USD","LU2462157665.USD","LU0708994859.HKD","LU0029864427.USD","LU0889565916.HKD","AZNH","LU2089984988.USD","LU1267930573.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110335435","title":"美股夜盤 | 芯片、存儲、光通信概念股拉升，康寧升逾5%、英特爾、美光科技升逾3%；阿斯利康跌超7%，新藥臨床試驗未達預期","url":"https://stock-news.laohu8.com/highlight/detail?id=1110335435","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110335435?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 15:18","pubTimestamp":1783581505,"startTime":"0","endTime":"0","summary":"7月9日，美股夜盘时段，芯片股拉升，英特尔、迈威尔科技涨超3%，ARM涨超2%；存储概念股走高，美光科技、西部数据涨超3%，希捷科技涨超2%，闪迪涨1.5%；光通信概念股走高，康宁涨超5%，Applied Optoelectronics、Coherent涨超3%，Credo Technology、Lumentum Holdings涨超2%；阿斯利康跌超7%，此前其治疗神经系统疾病的药物WAINUA晚期临床试验未达预期。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2417539215.USD","LU2357305700.SGD","BK4543","LU2048586759.USD","XNTK","LU0061475181.USD","LU2148611432.USD","XSD","LU2272731865.HKD","LU0323591593.USD","LU0056508442.USD","LU2764263039.SGD","LU2237443549.SGD","IE00BJLML261.HKD","LU0127658192.USD","GB00BDT5M118.USD","BK4529","SOXY","WUGI","LU0889565833.HKD","LU2102340556.USD","BK4007","LU2322448791.USD","AZN","CHAT","LU0321505868.SGD","IE000SO60NU8.SGD","HK0000304805.HKD","LU0719512351.SGD","LU1323610961.USD","LU0310800379.SGD","LU2720916845.USD","SOXX","IE000M9KFDE8.USD","QQQA","LU1861215975.USD","LU2764263203.CNY","LU0096364046.USD","LEGR","SMHX","LU0889566641.SGD","LU0289739699.SGD","LU1720051108.HKD","BK4532","BK4512","MUD","DRIV","HK0000304797.USD","LU2168564149.EUR","LU2286300806.USD","IE00B7SZLL34.SGD","IXN","LU0154236417.USD","IE000MB6IJN5.SGD","IE00BK4W5L77.USD","CNAV","IE0002270589.USD","LU0149725797.USD","LU2272731600.USD","FXL","LU0203345920.USD","AIQ","BMED","BK4535","BK4588","LU1852331112.SGD","LU0859254822.USD","BK4533","SSG","LU1267930813.SGD","LU2543165471.USD","LU0348723411.USD","PTF","IE00B5949003.HKD","LU1868836914.USD","LU2054465674.USD","LU1992135399.USD","LU2456880835.USD","LU2462157665.USD","LU2471134879.HKD","INTC","LU1989764748.USD","LU0787776722.HKD","IE00B19Z3581.USD","LU2237443622.USD","EGGY","LU0274383776.USD","LU1316542783.SGD","BK4568","LINT","LU1868836757.USD","LU2471134952.CNY","JGRO","LU2211815571.USD","LU2265009873.SGD","LU2168563687.JPY","LU2764262908.HKD","LU1868837300.USD","MULL","LU2272731782.SGD","LU2458330243.SGD","IE0009356076.USD","EMSF","BK4612","SOXS","BK4550","LU0109392836.USD","BK4602","LU0097036916.USD","USD","LU2360107168.USD","LU0321505439.SGD","LU1992135472.HKD","LU2089984988.USD","LU2931357623.SGD","ARTY","LU2468319806.SGD","IE00B3T34201.USD","LU2750360641.GBP","BK4553","INTW","IE00B1XK9C88.USD","BK4554","LU2471134523.USD","LU1989764664.SGD","IE00B19Z3B42.SGD","SOXQ","LU2237443465.HKD","LU0157215616.USD","FAI","LU1861220033.SGD","LU1868837136.USD","IE00BFMHRM44.USD","IE000F7OJYX1.SGD","SG9999001424.SGD","LU2237443978.SGD","TRFK","USXF","CHPY","LU2357627491.SGD","LU2458330169.SGD","LU0081259029.USD","BK4575","FTXL","LU1914381329.SGD","IBBQ","TTEQ","IE0034235303.USD","RULE","VGT","GLW","AZNH","CHPS","BK4515","LU0029864427.USD","MU","LU2089985449.USD","BK4527","SMH","LU1548497426.USD","WLDR","BK4148","TEKX","LU2168564495.EUR","LU2322448957.HKD","LU2236285917.USD","BK4534","LU2750360997.AUD","GLWG","BK4579","LU0432979614.USD","LU0128525929.USD","AIS","BK4605","IE00BWXC8680.SGD","LU1803068979.SGD","IE000WAW04H5.SGD","EFIV","LU0792757196.USD","LU0238689110.USD","LU0683600562.USD","LU2168564222.USD","CGGO","LU1267930573.SGD","LU0082616367.USD","LU1720051017.SGD","BAI","FDTX","LU2168564065.EUR","LU0320765992.SGD","LU2360106780.USD","SIXG","IE00BK4W5M84.HKD","LU2250418816.HKD","IE000BZT7R73.USD","159813","LU0642271901.SGD","LU0708994859.HKD","LU2237443895.HKD","LU0058720904.USD","LU0889565916.HKD","LU1829250122.USD","SHOC","BK4141","LU2290526834.HKD","IE0000B7K699.USD","IE00BKDWB100.SGD","LU2473716301.USD","LU2471134796.USD","AIFD","FTEC","LU0109394709.USD","PSI","LU1366333091.USD","LU1804176565.USD","XLK","MUU","SOXL","BK4585","LU2237443382.USD","LU0203347892.USD","BK4566","LU1868836591.USD","IETC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650419989","title":"歐股阿斯利康下跌9%此前其治療神經系統疾病的藥物WAINUA晚期臨床試驗未達預期。","url":"https://stock-news.laohu8.com/highlight/detail?id=2650419989","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650419989?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 15:12","pubTimestamp":1783581128,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BMED","LU2089984988.USD","LU1267930573.SGD","BK4568","LU1829250122.USD","LU2237443622.USD","BK4007","LU0109394709.USD","LU0889565916.HKD","LU0029864427.USD","VGK","VXUS","LU2462157665.USD","LU2237443465.HKD","LU2236285917.USD","LU0708994859.HKD","LU2237443382.USD","IE00B3T34201.USD","LU0310800379.SGD","LU0289739699.SGD","BK4585","IEV","LU0058720904.USD","AZN","AZNH","LU2417539215.USD","LU2468319806.SGD","LU2237443978.SGD","LU2237443549.SGD","LU0432979614.USD","BK4588","LU2237443895.HKD","IBBQ","LU0128525929.USD","LU2456880835.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650416399","title":"阿斯利康股價下跌8.9%，原因是WAINUA未能達到主要終點。","url":"https://stock-news.laohu8.com/highlight/detail?id=2650416399","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650416399?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 15:06","pubTimestamp":1783580794,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2237443549.SGD","LU0708994859.HKD","BK4568","LU1267930573.SGD","BK4007","LU2237443622.USD","LU2417539215.USD","BK4585","AZNH","LU1829250122.USD","LU0889565916.HKD","LU0058720904.USD","LU2468319806.SGD","AZN","LU2236285917.USD","LU2462157665.USD","LU0029864427.USD","LU2237443895.HKD","LU2237443382.USD","LU0128525929.USD","BK4588","LU0432979614.USD","LU2237443465.HKD","LU0289739699.SGD","IE00B3T34201.USD","LU0310800379.SGD","LU0320765992.SGD","LU2089984988.USD","LU2237443978.SGD","LU2456880835.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649993596","title":"阿斯利康發言人表示，正與英國國家醫療服務體系及英國國家健康與臨床優化研究所持續商討，以確定解決方案，支持患者獲得優赫得。","url":"https://stock-news.laohu8.com/highlight/detail?id=2649993596","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649993596?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 19:40","pubTimestamp":1783510837,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0058720904.USD","LU2237443549.SGD","LU0320765992.SGD","LU1267930573.SGD","LU0109394709.USD","LU2236285917.USD","LU2462157665.USD","BK4585","LU2456880835.USD","LU2237443978.SGD","AZN","LU0889565916.HKD","LU2237443465.HKD","LU0708994859.HKD","IE00B3T34201.USD","LU2468319806.SGD","LU2237443895.HKD","LU1829250122.USD","BK4007","LU0128525929.USD","BK4568","AZNH","LU2237443622.USD","LU0310800379.SGD","LU0432979614.USD","LU2417539215.USD","LU2237443382.USD","MEDX","LU0289739699.SGD","LU2089984988.USD","BK4588","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649969580","title":"中國生物製藥分別與阿斯利康、葛蘭素史克達成重要合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2649969580","media":"证券日报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649969580?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 15:55","pubTimestamp":1783497300,"startTime":"0","endTime":"0","summary":"7月8日，中国生物制药有限公司（以下简称“中国生物制药”）公告称，将自主研发的慢性阻塞性肺疾病（COPD）创新药TQC3721（PDE3/4抑制剂）海外权益以总额最高19亿美元授权给阿斯利康，创下近三年中国呼吸领域单产品交易额之最；同日，中国生物制药还宣布将进一步深化与葛兰素史克（GSK）的战略合作，获得GSK两款全球重磅呼吸创新药在中国内地的独家商业化权益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607083798367659.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607083798367659.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0128525929.USD","LU0029864427.USD","LU2237443549.SGD","LU2237443622.USD","LU0310800379.SGD","LU2089984988.USD","BK4007","AZNH","IE00BZ08YR35.GBP","LU0320765992.SGD","BK4532","LU2237443465.HKD","BK1191","LU0708994859.HKD","LU0289739699.SGD","IE00B3T34201.USD","IE00BZ08YS42.EUR","LU2462157665.USD","LU2417539215.USD","GSK.UK","LU0109394709.USD","01177","AZN","HK0000165453.HKD","GSK","GSKH","LU2237443382.USD","BK4568","BK4588","BK1515","IE00BZ08YT58.USD","LU1829250122.USD","BK1521","LU2237443895.HKD","LU0058720904.USD","BK1589","LU2237443978.SGD","LU0889565916.HKD","LU1267930573.SGD","LU2456880835.USD","LU2236285917.USD","LU2468319806.SGD","LU0432979614.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649500419","title":"慢阻肺藥物市場掀起交易熱潮，阿斯利康19億美元拿下這款中國創新藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2649500419","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649500419?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 13:42","pubTimestamp":1783489327,"startTime":"0","endTime":"0","summary":"继海思科之后，又有一家国产药企的慢性阻塞性肺疾病（COPD，下称慢阻肺）创新药管线达成对外授权交易。7月8日上午，中国生物制药（01177.HK）发布公告称，公司将TQC3721（PDE3/4抑制剂）海外权益以总额最高19亿美元授权给阿斯利康。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607083798231670.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607083798231670.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0029864427.USD","LU0320765992.SGD","LU2462157665.USD","AZN","KURE","LU0109394709.USD","BK4588","LU1829250122.USD","AZNH","BK4585","LU0289739699.SGD","LU2089984988.USD","LU2237443549.SGD","LU2236285917.USD","BK4007","LU2237443978.SGD","LU0128525929.USD","LU2237443622.USD","IE00B3T34201.USD","LU0708994859.HKD","LU2468319806.SGD","LU2237443465.HKD","LU2417539215.USD","LU2237443382.USD","LU2237443895.HKD","LU2456880835.USD","BK4568","LU0058720904.USD","LU1267930573.SGD","LU0432979614.USD","LU0889565916.HKD","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649464959","title":"港股異動 | 中國生物製藥(01177)早盤升逾4% 附屬與阿斯利康就TQC3721訂立獨家授權協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2649464959","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649464959?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 09:33","pubTimestamp":1783474437,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国生物制药早盘涨超4%，截至发稿，涨3.94%，报5.01元，成交额8286.17万港元。消息面上，7月8日，中国生物制药发布公告，集团附属公司正大天晴药业集团股份有限公司已与阿斯利康就集团自主研发的PDE3/4抑制剂订立独家授权协议。根据协议条款，集团将授予阿斯利康在中国以外地区开发、生产及商业化TQC3721的独家许可。阿斯利康还将获得TQC3721特定开发方案的全球独家许可。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464496.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2468319806.SGD","LU2237443382.USD","LU2089984988.USD","HK0000165453.HKD","LU1829250122.USD","BK1515","LU0029864427.USD","LU2237443978.SGD","AZN","KCAI","BK1589","IE00BZ08YS42.EUR","LU2236285917.USD","BK1521","LU1267930573.SGD","IE00BZ08YT58.USD","LU2456880835.USD","AZNH","LU0058720904.USD","LU2237443465.HKD","IE00B3T34201.USD","BK1191","LU0320765992.SGD","LU0432979614.USD","LU0109394709.USD","LU0310800379.SGD","LU2417539215.USD","LU2462157665.USD","BK4588","LU0128525929.USD","LU2237443895.HKD","BK4007","LU0289739699.SGD","LU0889565916.HKD","LU2237443622.USD","BK4585","VXUS","01177","BK4568","LU2237443549.SGD","IE00BZ08YR35.GBP","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649558469","title":"最高19億美元，中國生物製藥與阿斯利康達成TQC3721獨家授權合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2649558469","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649558469?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 07:46","pubTimestamp":1783467993,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2237443895.HKD","LU2237443622.USD","LU2456880835.USD","LU1829250122.USD","LU2462157665.USD","LU2089984988.USD","LU2237443382.USD","LU1267930573.SGD","LU0289739699.SGD","LU2237443465.HKD","BK4007","LU2237443978.SGD","LU2468319806.SGD","AZNH","LU2236285917.USD","LU0320765992.SGD","BK4568","LU0889565916.HKD","LU0058720904.USD","LU0128525929.USD","LU0029864427.USD","IE00B3T34201.USD","BK4585","LU2237443549.SGD","LU0708994859.HKD","LU2417539215.USD","LU0109394709.USD","LU0310800379.SGD","BK4588","AZN","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649958069","title":"中國生物製藥：與阿斯利康就TQC3721簽訂獨家許可協議，阿斯利康獲得TQC3721在中國境外的獨家授權，該協議可獲得2","url":"https://stock-news.laohu8.com/highlight/detail?id=2649958069","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649958069?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 06:06","pubTimestamp":1783461965,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0109394709.USD","LU2468319806.SGD","LU0320765992.SGD","LU1829250122.USD","LU2462157665.USD","AZN","LU2089984988.USD","LU2237443549.SGD","LU2236285917.USD","LU2237443622.USD","LU0310800379.SGD","LU2456880835.USD","LU0432979614.USD","LU0029864427.USD","LU2237443382.USD","LU2237443978.SGD","BK4007","BK4588","AZNH","LU0708994859.HKD","LU0058720904.USD","BK4585","LU0889565916.HKD","LU2237443895.HKD","IE00B3T34201.USD","LU0128525929.USD","BK4568","LU2417539215.USD","LU1267930573.SGD","LU0289739699.SGD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649939231","title":"數據簡報-隨着小型企業不斷湧現，減肥藥的上市競爭日益白熱化","url":"https://stock-news.laohu8.com/highlight/detail?id=2649939231","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649939231?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 00:13","pubTimestamp":1783440834,"startTime":"0","endTime":"0","summary":"数据简报-随着小型企业不断涌现，减肥药的上市竞争日益白热化在第1、2和25段中补充了Kailera Therapeutics公司肥胖症药物的详细信息路透7月7日-凯莱拉制药的KLRA.O口服减肥药在中国开展的一项晚期临床试验中，帮助患者在第44周时减重 ，最高可达体重的10.9%。这两种药物目前均处于临床前试验阶段。华东制药中国华东制药公司的口服减肥候选药物HDM1002，在中国针对超重或肥胖受试者进行的一项早期研究中，使体重最多减少了6.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4T4391IA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014880.SGD","LU0786609619.USD","SG9999001176.USD","CANC","LU0265550946.USD","SG9999015341.SGD","LU0109391861.USD","LU0323591593.USD","LU2237443978.SGD","LU2417539215.USD","LU1917777945.USD","GB00BDT5M118.USD","LU0980610538.SGD","BK1589","LU0859254822.USD","LU1162221912.USD","LU0106261372.USD","LU2097828474.EUR","LU0965509010.AUD","IE00BLSP4239.USD","LU1066051225.USD","LU0354030511.USD","LU0225284248.USD","LU2063271972.USD","LU2023250330.USD","SG9999015945.SGD","IE00BZ1G4Q59.USD","LU1929549753.HKD","LU1829250122.USD","LU0353189763.USD","BK4559","LU0070302665.USD","MEDI","LU1145028129.USD","BK4599","LU1291159041.SGD","LU1988902786.USD","THNR","BK4534","LU0256863811.USD","LU2168564065.EUR","SG9999018865.SGD","LU2168564222.USD","IE00BSNM7G36.USD","LU2491050154.USD","LU0265550359.USD","LU0170899867.USD","LU0006306889.USD","LU1066053197.SGD","LU2491050071.SGD","LU0943347566.SGD","LU2361044865.SGD","LU1989772923.USD","LU2112291526.USD","GPCR","IE00B4R5TH58.HKD","LU1232071149.USD","LU1093756168.USD","LU1814569148.SGD","IXJ","IE0002141913.USD","LU1069344957.HKD","RXL","LLYX","LU1267930573.SGD","LU0965509101.SGD","SG9999015952.SGD","BK4532","LU1061106388.HKD","LU2237438978.USD","HK0000165453.HKD","LU0385154629.USD","LU1035775433.USD","IE00BKDWB100.SGD","IE00BBT3K403.USD","LU0154236417.USD","LU2089284900.SGD","LLYZ","LU1868836914.USD","LU2462157665.USD","LU0889565916.HKD","03692","SG9999014898.SGD","LU0133085943.USD","LU2028103732.USD","LU2237443622.USD","LU0683600562.USD","LU0310800379.SGD","IE00B1XK9C88.USD","LU2552382132.HKD","ELIS","IYH","LU0455707207.USD","LU0266013472.USD","LU1069347547.HKD","LU2552382215.SGD","LU2125154935.USD","IE000M9KFDE8.USD","FHLC","HRTS","LU0320765059.SGD","LU2023251221.USD","LU2461242641.AUD","LU2023250504.SGD","LU0345770993.USD","LU0820562030.AUD","LU1868837300.USD","LU2236285917.USD","LU2357305700.SGD","LU2328871848.SGD","LU0502904849.HKD","LU0985481810.HKD","IE00BK4W5L77.USD","SGXZ31699556.SGD","LU2361044949.HKD","LU1267930730.SGD","LU0289739699.SGD","LU1989772840.SGD","IE00BJT1NW94.SGD","LU1127390331.HKD","LU0203201768.USD","LU0320765646.SGD","LU0648001328.SGD","LU2111349929.HKD","MEDX","KLRA","IE0004445015.USD","SG9999003800.SGD","LU2211815571.USD","LU1571399168.USD","LU2237443465.HKD","LU0058720904.USD","LU0354030438.USD","BK4592","LU2089984988.USD","LU0306806265.USD","IE00B19Z3B42.SGD","LU1868837136.USD","LU1548497426.USD","BK1574","JDOC","LU1699723380.USD","LU1064131342.USD","LU2125154778.USD","BK4568","LU2746668461.USD","LU0158827781.USD","LU0203347892.USD","LU1280957306.USD","LLY","IE00BJJMRY28.SGD","IE00B4JS1V06.HKD","LU0882574139.USD","LU1057294990.SGD","BK4581","LU0964807845.USD","LU0708995401.HKD","LU0238689110.USD","LU0417517546.SGD","LU1941712264.USD","IE0004445239.USD","PFE","IE00BN8TJ469.HKD","LU1934455277.USD","IE0002270589.USD","LU1868836591.USD","BK4139","BK1161","LU0109394709.USD","IE00BJJMRX11.SGD","LU2125909247.SGD","SG9999015358.SGD","SG9999011175.SGD","LU1969619763.USD","LU2357627491.SGD","IE00BWXC8680.SGD","IE00BFTCPJ56.SGD","LU1035773651.USD","LU0823434740.USD","AGNG","LU0203345920.USD","BK4585","LU0210536198.USD","LU0820561909.HKD","LU0985320562.USD","SG9999013999.USD","LU1037948897.HKD","PJP","LU0965509283.SGD","LU0128525929.USD","LU1894683348.USD","LU0820561818.USD","IE00BKPKM429.USD","LU1551013342.USD","LU0471298777.SGD","LU0198837287.USD","LU1323610961.USD","LU0211331839.USD","IHE","LU2361045086.USD","LU0079474960.USD","LU1066051498.USD","IE00BFSS7M15.SGD","SG9999014567.USD","01672","LU1430594728.SGD","LU0306807586.USD","OZEM","LU0321505868.SGD","BK1583","LLII","LU2756315318.SGD","BK1515","LU2471134952.CNY","IE00BKVL7J92.USD","LU0225283273.USD","SG9999014906.USD","LU0477156953.USD","LU2471134523.USD","BK4516","LU2023250843.SGD","LU0787776722.HKD","LU1974910355.USD","LU2108987350.USD","LU2433249047.HKD","LU1551013425.SGD","LU2089283258.USD","LU0456855351.SGD","IE00B1BXHZ80.USD","LU0029864427.USD","LU2097828557.USD","BK4588","LU0708994859.HKD","IE0001KFT4U8.USD","BMED","CURE","SG9999014542.SGD","LU0061475181.USD","VKTX","AZNH","BK4550","LU1066051811.HKD","LU0321505439.SGD","SG9999015978.USD","LU1093756325.SGD","LU2237443382.USD","LU2488822045.USD","LU2242644610.SGD","IE00BJJMRZ35.SGD","SG9999018857.SGD","LU0471298694.HKD","SGXZ57979304.SGD","LU0640476718.USD","LU1629891620.HKD","SG9999002224.SGD","LU0114720955.EUR","LU0861579265.USD","LU0320765992.SGD","IE00B775H168.HKD","LU2750360641.GBP","LU0208291251.USD","LU2896262040.SGD","SG9999001176.SGD","LU1804176565.USD","SGXZ81514606.USD","LU2265009873.SGD","LU0868494708.USD","MRK","SG9999001440.SGD","LU2746668974.SGD","LU1989771016.USD","LU0345770308.USD","LU0130517989.USD","LU2168564495.EUR","IE00B3T34201.USD","VHT","LU2552382058.USD","SG9999014914.USD","LU2324357040.USD","LU0823416689.USD","IE0009355771.USD","LU1023059063.AUD","AZN","LU1037948541.HKD","01801","LU2264538146.SGD","ILDR","LU0097036916.USD","LU2168563687.JPY","LU0256863902.USD","LU0225771236.USD","LU2596442595.SGD","LU0122379950.USD","XLV","LU2471134879.HKD","LU0965508806.USD","SG9999014559.SGD","LU0882574055.USD","LU0432979614.USD","KURE","BK1191","GDOC","LU2237443549.SGD","LU2125909593.SGD","LU0320765489.SGD","IE00BLSP4452.SGD","PPH","IE00BJLML261.HKD","NVOX","IE00B7KXQ091.USD","FTXH","LU2360106947.USD","IE00B2B36J28.USD","LU2097828714.EUR","LU0130102774.USD","LU1894683264.USD","BK4007","LU0234572021.USD","NVOH","SG9999014575.USD","LU1712237335.SGD","LU0094547139.USD","LU2360032135.SGD","SGXZ99366536.SGD","LU1883839398.USD","LU1201861249.SGD","LU1585245621.USD","LU1366192091.USD","LU0823434583.USD","LU1720051017.SGD","LU0942090050.USD","IE0005OL40V9.USD","LU1116320901.HKD","LU0098860793.USD","ELIL","LU2087625088.SGD","NVO","LU0672654240.SGD","LU0466842654.USD","LU0203202063.USD","LU1868836757.USD","LU2106854487.HKD","SG9999017495.SGD","LU2756315664.SGD","IE00BFSS8Q28.SGD","LU0353189680.USD","LU1623119135.USD","SGXZ51526630.SGD","LU2750360997.AUD","LU2456880835.USD","LU1720051108.HKD","LU1116320737.USD","LU2097828805.USD","LU2237443895.HKD","LU0316494557.USD","LU1934455863.HKD","LU1941712348.USD","LU1934455194.USD","LU2097828631.EUR","BK4533","LU2471134796.USD","LU0689472784.USD","SG9999002232.USD","IE00BN29S564.USD","LU2491049909.HKD","PAWZ","LU2168564149.EUR","LU0096364046.USD","SG9999015986.USD","LU0868494617.USD","LU1923622614.USD","LU2213496289.HKD","IE00BK4W5M84.HKD","WDNA","LU0158827948.USD","LU1983299246.USD","IE00B19Z3581.USD","LU2602419157.SGD","LU2271345857.HKD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649620708","title":"阿斯利康(AZN)股票7月6日盤中下跌3.79%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2649620708","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649620708?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 23:15","pubTimestamp":1783350932,"startTime":"0","endTime":"0","summary":"• 阿斯利康与石药集团达成合作，交易总额高达17.7亿美元。\n• 受获利回吐、盈利预期修正以及监管管线不确定性影响，股价出现下跌。\n• Enhertu 获欧盟委员会批准用于治疗 HER2 阳性转移性实体瘤。","market":"hk","thumbnail":"https://resource.tradingkey.com/uploads/20251024/AstraZeneca-000ba9f6d3d446b080935cd9fe1dade4.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20251024/AstraZeneca-000ba9f6d3d446b080935cd9fe1dade4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262013535-market-movers-azn-20260706","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0320765992.SGD","LU2236285917.USD","LU0029864427.USD","LU0109394709.USD","LU0432979614.USD","LU2462157665.USD","LU2237443382.USD","LU1829250122.USD","LU2237443549.SGD","BK4568","LU0289739699.SGD","LU2089984988.USD","LU0128525929.USD","LU2468319806.SGD","LU2237443978.SGD","LU2237443465.HKD","LU2237443895.HKD","LU2417539215.USD","LU0058720904.USD","LU1267930573.SGD","LU2456880835.USD","LU2237443622.USD","LU0889565916.HKD","LU0708994859.HKD","BK4007","BK4585","IE00B3T34201.USD","AZN","AZNH","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648321696","title":"石藥集團盤初漲近7% 石藥集團與阿斯利康達成17.7億美元新合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2648321696","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648321696?lang=zh_tw&edition=fundamental","pubTime":"2026-07-03 09:41","pubTimestamp":1783042860,"startTime":"0","endTime":"0","summary":"　　石药集团早盘涨近7%，截至发稿，股价上涨4.64%，现报7.90港元，成交额2.37亿港元。　　石药集团宣布，与阿斯利康达成小核酸药物合作。　　根据该协议的条款，石药集团与阿斯利康将针对两个靶点共同发现和开发具备治疗肾脏疾病多种适应症潜力的临床前候选药物。石药集团将保留其中一个 PCC 在中国境内开发、生产和商业化的全部权益。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-03/doc-inifntfa5634037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01093","LU1807302812.USD","LU0708994859.HKD","LU1226288253.USD","HK0000165453.HKD","BK4568","IE00BZ08YS42.EUR","IE00B5MMRT66.SGD","LU1152091168.USD","BK1521","LU1993786604.SGD","BK4585","AZNH","LU1829250122.USD","LU0314109678.HKD","LU0889565916.HKD","IE00B543WZ88.USD","LU0072913022.USD","LU0058720904.USD","SG9999004220.SGD","AZN","LU2236285917.USD","LU2462157665.USD","LU0029864427.USD","IE00BZ08YR35.GBP","LU1951186391.HKD","LU0501845795.SGD","LU2237443382.USD","IE0008368742.USD","LU0128525929.USD","BK4588","LU0432979614.USD","LU2237443465.HKD","LU1152091754.HKD","LU1813983027.USD","LU0315179316.USD","LU1226288170.HKD","LU0289739699.SGD","IE00B3T34201.USD","LU0310800379.SGD","LU1328277881.USD","LU0880133367.SGD","BK1191","LU2089984988.USD","LU1226287792.SGD","LU2237443978.SGD","LU2456880835.USD","LU0326950275.SGD","LU0109394709.USD","IE00B031HY20.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":6,"totalSize":163,"code":"91000000","status":"200"}]}}